RESUMO
INTRODUCTION: The aim of this study is to establish the risk of thromboembolic events and evaluation of the use of venous thromboembolism prophylaxis in hospitalized medical patients and after discharge, and their concordance with protocols used in our hospital. MATERIAL AND METHODS: We performed a cross-sectional with prospective follow-up until hospital discharge. It included all medical patients in Internal Medicine, Pneumology and Oncology Departments. The patient's thromboembolic risk and type of thromboembolism prophylaxis indication during hospitalization and after discharge were determined. RESULTS: A total of 116 patients (52 in Internal Medicine Department, 35 in Pneumology Department and 29 in Oncology Department), with a mean age of 67 +/- 17 years (35 females; 81 males) were included. During hospitalization, 62.9% of the patients had a high risk of thromboembolic events, 3.4% a moderate risk, 23.3% low risk, and 10.3% had no risk. After discharge, these proportions were 35.6%, 3.8%, 24% and 34.6%, respectively. A total of 49.1% of the patients had an adequate indication of venous thromboembolism prophylaxis during the hospitalization and after discharge.
Assuntos
Anticoagulantes/uso terapêutico , Hospitalização , Alta do Paciente , Tromboembolia Venosa/epidemiologia , Tromboembolia Venosa/prevenção & controle , Idoso , Estudos Transversais , Uso de Medicamentos , Feminino , Humanos , Masculino , Estudos Prospectivos , Fatores de RiscoRESUMO
Introducción. El objetivo de este estudio es conocer el riesgo de enfermedad tromboembólica venosa (ETV) en pacientes médicos durante su ingreso y al alta hospitalaria, y estudiar los hábitos de prescripción de tromboprofilaxis y su adecuación a los protocolos utilizados en nuestro medio. Material y método. Para ello se realizó un estudio transversal con seguimiento prospectivo hasta el alta hospitalaria. Se incluyeron pacientes médicos de los Servicios de Medicina Interna, Neumología y Oncología, en los que se determinó el grado de riesgo de ETV y el tipo de indicación de tromboprofilaxis durante el ingreso y al alta hospitalaria. Resultados. Se incluyeron 116 pacientes (52 en medicina interna, 35 en neumología y 29 en oncología), con una media de edad de 67 ± 17 años (35 mujeres; 81 hombres). En el ingreso el 62,9% tenían alto riesgo de ETV, el 3,4% moderado, el 23,3% bajo y el 10,3% no tenían riesgo. Al alta hospitalaria estos porcentajes fueron de 35,6; 3,8; 24 y 34,6%, respectivamente. La proporción de pacientes con prescripción adecuada a la indicación fue del 49,1%, tanto durante el ingreso como al alta hospitalaria (AU)
Introduction. The aim of this study is to establish the risk of thromboembolic events and evaluation of the use of venous thromboembolism prophylaxis in hospitalized medical patients and after discharge, and their concordance with protocols used in our hospital. Material and methods. We performed a cross-sectional with prospective follow-up until hospital discharge. It included all medical patients in Internal Medicine, Pneumology and Oncology Departments. The patient's thromboembolic risk and type of thromboembolism prophylaxis indication during hospitalization and after discharge were determined. Results. A total of 116 patients (52 in Internal Medicine Department, 35 in Pneumology Department and 29 in Oncology Department), with a mean age of 67 ± 17 years (35 females; 81 males) were included. During hospitalization, 62.9% of the patients had a high risk of thromboembolic events, 3.4% a moderate risk, 23.3% low risk, and 10.3% had no risk. After discharge, these proportions were 35.6%, 3.8%, 24% and 34.6%, respectively. A total of 49.1% of the patients had an adequate indication of venous thromboembolism prophylaxis during the hospitalization and after discharge (AU)
Assuntos
Humanos , Tromboembolia/epidemiologia , Anticoagulantes/uso terapêutico , Fatores de Risco , Heparina de Baixo Peso Molecular/uso terapêutico , Alta do Paciente/estatística & dados numéricosRESUMO
El RD 1299/2006(1), por el que se establece el nuevo cuadrode EE PP, responde a la necesidad de actualizar el cuadro deEE PP existente en España(2) y de establecer nuevos criteriosde notificación y registro(3-5). Esta necesidad surge porque seconsidera un cuadro obsoleto, poco ágil en su manejo, sinun enfoque preventivo y sin criterios diagnósticos claros, loque provoca una infradeclaración, y por razones legales, yaque se trata de una disposición de aplicación y desarrollodel artículo 116 de la LGSS(6), a cuyo ámbito pertenece lanueva LPRL(7). Objetivo: Realizar una comparación descriptivaentre el antiguo cuadro de EE PP(2) y el nuevo cuadro establecido en el RD 1299/2006(1). Metodología: Estudio y análisis legislativo del RD 78/1995(2) y del RD 1299/2006(1)con revisión de la bibliografía más destacada y actualizada.Resultados y conclusiones: Tras el análisis de ambos cuadros,se observa un gran avance en cuanto a la declaración,clasificación y notificación de las EE PP en España. Queda pendiente analizar el verdadero impacto que supone este cambio legislativo en la realidad actual de las EE PP (AU)
Background: The Royal Decree 1299/2006 of November10th, which established the new legal framework for occupationaldiseases, represents an answer to the need to updatethe concept of such diseases in Spain and to establish new reportingand recording criteria. The previously existing frameworkwas considered obsolete and cumbersome and lackinga preventive approach and clear diagnostic criteria, leading tounder-reporting. Furthermore, there are also legal reasons.Objective: Descriptive comparison between the old and thenew frameworks of occupational disease. Methods: Legislativestudy and analysis of the two Royal Decrees concerned(1995/78 and 1299/2006) with a review of the pertinent andupdated bibliography. Results and conclusions: Considerableadvances are observed regarding reporting, classificationand recording of occupational diseases in Spain. The trueimpact of this legislative change on the current reality of occupationaldisease remains to be seen (AU)
